Dr Rao Papineni will deliver “Combinatorial energy based cancer therapeutics” at 17th International Conference for Radiation Research ICRR 2023 Canada.
Technologies: High-Throughput Integrated Radiation Clonogenic Assay & Spatial Radiation Treatment
The development of this product was supported through Grant-in-Aid from National Cancer Institute, NCI-SBIR
Nanomedicine: Radiation activated Photodynamic Cancer Therapy
The development of this product was supported through Grant-in-Aid from National Cancer Institute, NCI-SBIR
PH074 Anticancer PH477 Infection PH744 Countermeasure
One-Two Punch Polypharmacological Therapeutics: anticancer, senolytic, & antiviral properties
AI workflow in Preclinical & Translational Oncology
IAEA
International Atomic Energy Agency
Dr Papineni Joined IAEA- NCI meet from 30 October-1 November 2018 at Vienna establishing a Technical Manual for Intrinsic Radiation Sensitivity assay using clonogenic cell survival (TMIRS). Norms for the Dosimetry and interlaboratory experimentation harmonization.
A special issue of Translational Cancer Research (TCR) on “Applications of Nanotechnology in Radiation Research”, we showcase the innovative and novel approaches in the utility of nanotechnology in Radiation therapy.
PACT&Health is Awarded a Prestigious National Cancer Institute NCI SBIR contract to develop Anti-Cancer Radiation Drug Screening Platform.
September 2019
PACT&Health is pleased to receive a 1.9 M$ Contract Grant to develop a High-Throughput X-Ray Irradiation Platform to screen novel modulators for Clinical Cancer Radiotherapy.
"TECHNOLOGIES"
Towards Engineered Precision Assays and Poly Pharmacological Cure-Based Cancer Drug/ Therapy Solutions.
Our Vision
To provide a platform for Cancer Biology, Radiation Oncology, and Radiation Biology for utilizing advanced preclinical and translational technologies in improving biomarker database and impact precision cancer treatment globally. PACT & Health established in 2013, further focusses in developing Radiation modifying agents such as radiosensitizers and radioprotectants.
LATEST NEWS
-
Technological advancements in cancer diagnostics: Improvements and limitations
https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1764 -
Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012312/ -
Technological advancements in brachytherapy of cancer
https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1764 -
Development of radiation-triggered phosphor platform for localized activation in combinatory cancer treatment (July, 2021)
Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA Abstract A defined spatial and temporal control of induction of toxicity in response to external ionizing radiation such... -
Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs (July, 2021)
Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA Abstract Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a single-stranded RNA virus with largest genomes (∼ 29,800 bases) of...